Showing results (241-250 of 1,338) with videos related to
Sort By:
Pageof 134
Neuro-Oncology Advances|November 29, 2023
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohortKarin A van Garderen, Wies R Vallentgoed, Anna Lavrova, et al.Neuro-Oncology Advances|January 19, 2024
Homeostatic iron regulatory protein drives glioblastoma growth via tumor cell-intrinsic and sex-specific responsesKatie M Troike, Sabrina Z Wang, Daniel J Silver, et al.Neuro-Oncology Advances|March 12, 2024
DNA methylation landscapes in DIPG reveal methylome variability that can be modified pharmacologicallyAshley R Tetens, Allison M Martin, Antje Arnold, et al.Neuro-Oncology Advances|February 29, 2024
A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant gliomaRiley K Driscoll, Sean B Lyne, David J Voce, et al.Neuro-Oncology Advances|February 19, 2024
The potential of liquid biopsy for detection of the KIAA1549-BRAF fusion in circulating tumor DNA from children with pilocytic astrocytomaOlha Krynina, Teresita Díaz de Ståhl, Cecilia Jylhä, et al.Neuro-Oncology Advances|February 20, 2024
Long-term health-related quality of life in meningioma survivors: A mixed-methods systematic reviewSé Maria Frances, Louise Murray, Emma Nicklin, et al.Neuro-Oncology Advances|February 26, 2024
Does exogenous hormonal therapy affect the risk of glioma among females: A systematic review and meta-analysisGhady Alfuridy, Rana Alghamdi, Abdulaziz Alkhoshi, et al.Neuro-Oncology Advances|February 26, 2024
Identifying IDH-mutant and 1p/19q noncodeleted astrocytomas from nonenhancing gliomas: Manual recognition followed by artificial intelligence recognitionLei He, Hong Zhang, Tianshi Li, et al.Neuro-Oncology Advances|January 31, 2024
Rapid, economical diagnostic classification of ATRT molecular subgroup using NanoString nCounter platformBen Ho, Anthony Arnoldo, Yvonne Zhong, et al.Neuro-Oncology Advances|May 21, 2024
Nonclinical pharmacodynamics of boron neutron capture therapy using direct intratumoral administration of a folate receptor targeting novel boron carrierKohei Tsujino, Hideki Kashiwagi, Kai Nishimura, et al.Pageof 134